The mass spectrometry test result constitutes an independent prognostic factor
Next, we evaluated the prognostic value of MS testing at the three defined time points in a multivariable model, which included age at diagnosis, gender, treatment arm, R-ISS stages and gain(1q21) status (Fig. 